Dalfampridine
( DrugBank: Dalfampridine / KEGG DRUG: Dalfampridine )
2 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 4 | Primary lateral sclerosis | 1 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 13 | Multiple sclerosis | 12 |
4. Primary lateral sclerosis
Clinical trials : 6 / Drugs : 10 - (DrugBank : 6) / Drug target genes : 13 - Drug target pathways : 27
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
13. Multiple sclerosis
Clinical trials : 3,685 / Drugs : 1,932 - (DrugBank : 355) / Drug target genes : 263 - Drug target pathways : 237
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|